Ain Shams University
Cairo, Egypt
NCT Number: NCT03785041
Comparison between preemptive and postoperative intraarticular injection of tramadol on pain sensation after arthroscopy
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Cairo, Egypt
220 patients assigned for therapeutic knee arthroscopy were divided into four equal groups in this prospective comparative study. All patients received IAI of 20 ml (0.5%) levopubivacaine alone in Group C; with 100 mg tramadol as PE (Group PE), at end of surgery (Group PO) or divided as 50 mg tramadol + 20 ml 0.25 % levobupivacaine as PE and 50 mg trmadol + 20 ml 0.25 % levobupivacaine as PO (Group PE/PO). Numeric rating scale (NRS) was used to assess pain sensation. Duration till request of rescue analgesia and number of requests were recorded. Patients' satisfaction concerning efficacy of PO analgesia was assessed using Iowa Satisfaction with Anesthesia Scale.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intrarticular injection of tramadol in addition to levobupivacaine in different doses preemptive and postoperative
Other names: Tramadol 50 MG/ML, Tramadol 100 MG/ML, Levobupivacaine Hydrochloride 5MG/ML
Time frame: Pain assessment for 12 hours postoperative
Pain sensation after arthroscopy assessed by numeric rating scale depending upon patient facial appearance with severe patient expressing high score and no pain with lowest score
Ain Shams University
Other
Comparative Study Between Preemptive and Postoperative Intra-articualr Injection of Levobupivacaine and Tramadol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07586436
Neurologic Manifestations, Pain
View Trial Details